FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)

CUSIP: 31447P100

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+691,508
Put/Call ratio
0.37%
SEC-reported price per share
$11.22
Number of holders
55
Value change
+$8,238,895
Number of buys
28
Open additional details 1 more signal available
Number of sells
19
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
34,474,972

Security key

31447P100

Report period

Q4 2023

Institutions

55

Top holders

10

Ownership snapshot

Top reported holders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Southpoint Capital Adviso...
Disclosed value leader
Southpoint Capital Adviso...
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

Southpoint Capital Advisors LP leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Southpoint Capital Advisors LP's linked filing trail.
Comparable ownership Top 5
Southpoint Capital Advisors LP 12%
Sonic GP LLC 7%
Solas Capital Management, LLC 5%
Avoro Capital Advisors LLC 3.5%
DG Capital Management, LLC 3.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Southpoint Capital Advisors LP
13F
Company
13F
12%
$30,619,877
4,077,214 shares
30 Sep 2023
Sonic GP LLC
13F
Company
13F
7%
$18,079,251
2,407,357 shares
30 Sep 2023
Solas Capital Management, LLC
13F
Company
13F
5%
$12,959,008
1,725,567 shares
30 Sep 2023
Avoro Capital Advisors LLC
13F
Company
13F
3.5%
$9,012,000
1,200,000 shares
30 Sep 2023
DG Capital Management, LLC
13F
Company
13F
3.3%
$8,584,673
1,143,099 shares
30 Sep 2023
BlackRock Finance, Inc.
13F
Company
13F
2.5%
$6,346,259
845,041 shares
30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
55
Shares
15,010,968
Rows available
55
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
54
Q4 2023 holders
55
Holder diff
1
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .